Confirmed: Siemens Aims For H1 2018 IPO for Healthineers
Executive Summary
Siemens is planning to spin out its Healthineers business in an IPO slated for the first half of next year, the German conglomerate has confirmed. The move will give the health care business "the required currency and entrepreneurial flexibility" to grow in a fundamentally attractive market, it said. The announcement was made in conjunction with the group's reporting of its third quarter results for fiscal 2017, in which solid diagnostics imaging sales helped to boost the top line for Healthineers.
You may also be interested in...
Siemens Adds Infectious Disease Tests With Luxembourg's Fast-Track Diagnostics
Siemens Healthineers has signed an agreement to acquire Luxembourg-based Fast Track Diagnostics (FTD) the developer of diagnostics that can distinguish between viral, bacterial, or other infections in one test. The deal comes as Siemens is shaping up to float Healthineers, as an independently publicly-listed company.
Clinica 100: Top Spot Soon Within Medtronic’s Grasp; More Change In 2016
Medtronic may have pulled off the biggest merger in medtech history, but Johnson & Johnson has once again held on to its number one spot in this year’s Clinica 100 league table – but only just. With J&J having done more streamlining in 2015 and Medtronic in line to benefit from the addition of Covidien sales for a full fiscal year, the next edition of our league table in 2016 will very likely see a new leader.
Covidien - world's fifth largest healthcare products company - begins trading
Covidien, the former healthcare division of the $41bn conglomerate Tyco International, made its debut as an independent company on the New York Stock Exchange and in Bermuda on Monday (July 2). The move comes nearly a year after Tyco International first revealed it was considering splitting up into three separate and more manageable businesses.